Associations between gonadotropins, testosterone and β amyloid in men at risk of Alzheimer's disease. (Q48325860)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089633%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

title

Associations between gonadotropins, testosterone and β amyloid in men at risk of Alzheimer's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089633%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

0 references

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089633%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089633%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089633%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089633%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089633%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089633%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089633%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

AIBL Research Group

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089633%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

D Henley

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089633%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

D Ames

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089633%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

K A Ellis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089633%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

V B Gupta

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089633%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Q-X Li

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089633%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

C L Masters

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089633%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

C C Rowe

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089633%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

K Taddei

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089633%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

V L Villemagne

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089633%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

language of work or name

English

0 references

publication date

23 October 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089633%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089633%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089633%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089633%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

69-75

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23089633%20AND%20SRC:MED&resulttype=core&format=json

Endogenous sex hormones and cognitive function in older men.

16 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Interaction between testosterone and apolipoprotein E epsilon4 status on cognition in healthy older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

An association of elevated serum gonadotropin concentrations and Alzheimer disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Free testosterone and risk for Alzheimer disease in older men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Low androgenization index in elderly women and elderly men with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Testosterone reduces neuronal secretion of Alzheimer's beta-amyloid peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Testosterone stimulates rapid secretory amyloid precursor protein release from rat hypothalamic cells via the activation of the mitogen-activated protein kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Testosterone attenuates beta-amyloid toxicity in cultured hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Chemical andropause and amyloid-beta peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Androgens modulate beta-amyloid levels in male rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Hormonal profiles after the menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

The control of gonadotrophin secretion by ovarian steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

The aging male hypothalamic-pituitary-gonadal axis: pulsatility and feedback

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

In men older than 70 years, total testosterone remains stable while free testosterone declines with age. The Health in Men Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Low free testosterone is an independent risk factor for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Amyloid beta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Imaging beta-amyloid burden in aging and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

R: A Language for Data Analysis and Graphics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

A direct approach to false discovery rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

The positive false discovery rate: a Bayesian interpretation and the q -value

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Strong control, conservative point estimation and simultaneous conservative consistency of false discovery rates: a unified approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Statistical significance for genomewide studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Are memory complaints predictive for dementia? A review of clinical and population-based studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Subjective Memory Complaints and Cognitive Impairment in Older People

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Association of cardiovascular factors and Alzheimer's disease plasma amyloid-beta protein in subjective memory complainers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Effect of chronic hCG administration on Alzheimer's-related cognition and A beta accumulation in PS1KI mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Direct exposure of guinea pig CNS to human luteinizing hormone increases cerebrospinal fluid and cerebral beta amyloid levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Apolipoprotein E, Dementia, and Cortical Deposition of β-Amyloid Protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Variation in thyroid function in subclinical hypothyroidism: importance of clinical follow-up and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Clinical and pathological correlates of apolipoprotein E ?4 in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.147

Memory complaints as a precursor of memory impairment in older people: a longitudinal analysis over 7-8 years

21 January 2018

1 reference

12 December 2020

Relationship between testosterone, sex hormone binding globulin and plasma amyloid beta peptide 40 in older men with subjective memory loss or dementia.

1 reference

12 December 2020

Association between memory complaints and incident Alzheimer's disease in elderly people with normal baseline cognition.

1 reference

12 December 2020

Luteinizing hormone levels are positively correlated with plasma amyloid-beta protein levels in elderly men.

1 reference

12 December 2020

Testosterone and gonadotropin levels in men with dementia.

1 reference

12 December 2020

Elevated gonadotropin levels in patients with Alzheimer disease.

1 reference

12 December 2020

Serum total testosterone is lower in men with Alzheimer's disease.

1 reference

12 December 2020